<DOC>
	<DOCNO>NCT00002689</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy combine chemotherapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness brachytherapy follow external-beam radiation therapy plus chemotherapy treating patient pancreatic cancer remove surgically .</brief_summary>
	<brief_title>Radiation Therapy Plus Chemotherapy Treating Patients With Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine response/remission rate , survival , degree local control interstitial colloidal phosphorus P32 follow external beam radiotherapy chemotherapy patient unresectable pancreatic cancer . OUTLINE : Patients stratify accord prior therapy ( yes v ) . Patients receive dexamethasone intratumorally , macroaggregated albumin interstitial phosphorus P32 intratumorally . Most patient receive second course brachytherapy . Patients proceed chemoradiotherapy begin 7-14 day brachytherapy . Radiotherapy administer 5 day week 6.4 week . Fluorouracil IV administer every day 4 dos week 1 2 . Patients follow monthly 1 year every 3 month thereafter . PROJECTED ACCRUAL : A total 48 patient accrue study .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven unresectable adenocarcinoma pancreas limited head , body , tail pancreas Diameter great 5 cm Volume great 66 mL No ascites ( without tumor cell ) No endoscopically proven tumor penetration duodenum stomach PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 70100 % Hematopoietic : WBC least 3,000/mm3 Platelet count least 100,000/mm3 Hemoglobin least 9 g/dL ( transfusion allow ) Hepatic : No hepatic disease At least 50 % uptake technetiumsulfur colloid normal liver cirrhosis suspect No vascular occlusion portal system Renal : Creatinine great 1.5 mg/dL BUN great 25 mg/dL Other : No Crohn 's disease , ulcerative colitis , inflammatory bowel disease Not pregnant PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : If prior chemotherapy , test dose colloidal phosphorous P32 administer prior attempt treatment Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy pancreas , liver , upper gastrointestinal tract Surgery : No complete surgical resection No splenectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>stage I pancreatic cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>adenocarcinoma pancreas</keyword>
</DOC>